publication venue for
- Enoxaparin for long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency 2024
- Role of mTOR1 and mTOR2 complexes in MEG-01 physiology. 969-981. 2024
- Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study 2022
- Outcome of cancer-associated venous thromboembolism is more favorable among patients with hematologic malignancies than in those with solid tumors. 1594-1602. 2022
- Real.life treatment of venous thromboembolism with direct oral anticoaculants: the influence of recommended dosing and regimens. 392-389. 2022
- Machine learning to predict outcomes in patients with acute pulmonary embolism who prematurely discontinued anticoagulant therapy. 2021
- Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores. . 319-328. 2021
- Predictors of Post-Thrombotic Ulcer after AcuteDVT: The RIETE Registry. 320-328. 2021
- Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism. 808-815. 2021
- Prognostic significance of concomitant superficial vein thrombosis in patients with deep vein thrombosis of the lower limbs. 2021
- Clinical characteristics and outcomes of women presenting with venous thromboembolism during pregnancy and post-partum period: Findings from the RIETE Registry. . 1454-1462. 2020
- Different types of statins and all-cause mortality in patients receiving anticoagulation for venous thromboembolism. Validation study from the RIETE Registry. . 236-244. 2020
- Outcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to Anticoagulation. . 1035-1044. 2020
- Psychotropic drugs and outcome in patients receiving anticoagulant therapy for venous thromboembolism. 620-626. 2020
- Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant prematurely. 61-68. 2020
- Direct oral anticoagulants or standard anticoagulant therapy in fragile patients with venous thromboembolism. . 67-76. 2019
- Clinical course of venous thromboembolism in patients with pancreatic cancer: insights from the RIETE Registry. 1119-1122. 2018
- Predictors of post-thrombotic ulcer after acute DVT: the RIETE Registry. . 320-328. 2018
- Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE Registry. . 1630-1636. 2017
- Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.. 1192-1198. 2017
- Real-life treatment of venous thromboembolism with direct oral anticoagulants. The influence of recommended dosing and regimens.. 382-389. 2017
- Dynamics of case-fatality rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. . 834-843. 2013
- Mujer de 44 años con Síndrome de Vena Cava Superior 2013
- Platelet count and outcome in patients with acute venous thromboembolism. 1025-1034. 2013
- Acute Venous Thromboembolism after non-major orthopedic surgery or post-traumatic limb immobilization.. 739-741. 2011
- Effect of the time of diagnosis on outcome in patients with acute venous thromboembolism: Findings from the RIETE registry. . 45-51. 2011
- Venous thromboembolism in patients with intracranial haemorrhage.. 750-752. 2011
- Venous Thromboembolism during Pregnancy, Postpartum or Contraceptive Use. Findings from the RIETE Registry. 306-311. 2010
- Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects. 240-244. 2007